CoChat

Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cells

Open access
Morsli, Samir, Doherty, Gary J., Muñoz-Espín, Daniel · 2022 · Mechanisms of Ageing and Development
Cited by 42

The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.

Abstract

Pharmacologically active compounds that manipulate cellular senescence (senotherapies) have recently shown great promise in multiple pre-clinical disease models, and some of them are now being tested in clinical trials. Despite promising proof-of-principle evidence, there are known on- and off-target toxicities associated with these compounds, and therefore more refined and novel strategies to improve their efficacy and specificity for senescent cells are being developed. Preferential release of drugs and macromolecular formulations within senescent cells has been predominantly achieved by exploiting one of the most widely used biomarkers of senescence, the increase in lysosomal senescence-associated β-galactosidase (SA-β-gal) activity, a common feature of most reported senescent cell types. Galacto-conjugation is a versatile therapeutic and detection strategy to facilitate preferential targeting of senescent cells by using a variety of existing formulations, including modular systems, nanocarriers, activatable prodrugs, probes, and small molecules. We discuss the benefits and drawbacks of these specific senescence targeting tools and how the strategy of galacto-conjugation might be utilised to design more specific and sophisticated next-generation senotherapeutics, as well as theranostics agents. Finally, we discuss some innovative strategies and possible future directions for the field.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.mad.2021.111618

Cites

137 of 137 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 137 references

Research works printed but not linked: 100

  1. Agostini, 2012, Targeted cargo delivery in senescent cells using capped mesoporous silica nanoparticles, Angew. Chem. Int. Ed. Engl., 51, 10556, 10.1002/anie.201204663 · DOI · Paper page
  2. Aguilera, 2009, Dasatinib in chronic myeloid leukemia: a review, Ther. Clin. Risk Manag., 5, 281
  3. Asanuma, 2015, Sensitive beta-galactosidase-targeting fluorescence probe for visualizing small peritoneal metastatic tumours in vivo, Nat. Commun., 6, 6463, 10.1038/ncomms7463 · DOI · Paper page
  4. Baker, 2020, Altered iron metabolism and elevated cellular senescence in COPD small airway epithelial cells, Eur. Respir. J., 56, 3707
  5. Cang, 2015, ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development, J. Hematol. Oncol., 8, 129, 10.1186/s13045-015-0224-3 · DOI · Paper page
  6. Chan, 2019, Short-term gain, long-term pain: the senescence life cycle and cancer, Genes Dev., 33, 127, 10.1101/gad.320937.118 · DOI · Paper page
  7. Childs, 2016, Senescent intimal foam cells are deleterious at all stages of atherosclerosis, Science, 354, 472, 10.1126/science.aaf6659 · DOI · Paper page
  8. Cho, 2020, CD9 induces cellular senescence and aggravates atherosclerotic plaque formation, Cell Death Differ., 27, 2681, 10.1038/s41418-020-0537-9 · DOI
  9. Chu, 2020, Rapid senescence-like response after acute injury, Aging Cell, 19, 10.1111/acel.13201 · DOI
  10. Coppe, 2010, The senescence-associated secretory phenotype: the dark side of tumor suppression, Annu. Rev. Pathol., 5, 99, 10.1146/annurev-pathol-121808-102144 · DOI · Paper page
  11. Cui, 2013, Notch3 functions as a tumor suppressor by controlling cellular senescence, Cancer Res., 73, 3451, 10.1158/0008-5472.CAN-12-3902 · DOI
  12. De Mera-Rodriguez, 2021, Is Senescence-Associated beta-Galactosidase a Reliable in vivo Marker of Cellular Senescence During Embryonic Development?, Front. Cell Dev. Biol., 9, 10.3389/fcell.2021.623175 · DOI · Paper page
  13. Di Leonardo, 1994, DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts, Genes Dev., 8, 2540, 10.1101/gad.8.21.2540 · DOI · Paper page
  14. Dimri, 1995, A biomarker that identifies senescent human cells in culture and in aging skin in vivo, Proc. Natl. Acad. Sci., 92, 9363, 10.1073/pnas.92.20.9363 · DOI · Paper page
  15. Ekpenyong-Akiba, 2019, Detecting and targeting senescent cells using molecularly imprinted nanoparticles, Nanoscale Horiz., 4, 757, 10.1039/C8NH00473K · DOI · Paper page
  16. Ekpenyong-Akiba, 2020, Amelioration of age-related brain function decline by Bruton’s tyrosine kinase inhibition, Aging Cell, 19, 10.1111/acel.13079 · DOI
  17. Galiana, 2020, Preclinical antitumor efficacy of senescence-inducing chemotherapy combined with a nanoSenolytic, J. Control. Release, 323, 624, 10.1016/j.jconrel.2020.04.045 · DOI · Paper page
  18. Gey, 2013, Metabolic changes during cellular senescence investigated by proton NMR-spectroscopy, Mech. Ageing Dev., 134, 130, 10.1016/j.mad.2013.02.002 · DOI
  19. Going, 2002, ’SEnescence-associated’ beta-galactosidase activity in the upper gastrointestinal tract, J. Pathol., 196, 394, 10.1002/path.1059 · DOI · Paper page
  20. Gray-Schopfer, 2006, Cellular senescence in naevi and immortalisation in melanoma: a role for p16?, Br. J. Cancer, 95, 496, 10.1038/sj.bjc.6603283 · DOI · Paper page
  21. Gu, 2016, Real-time tracking and in vivo visualization of beta-galactosidase activity in colorectal tumor with a ratiometric near-infrared fluorescent probe, J. Am. Chem. Soc., 138, 5334, 10.1021/jacs.6b01705 · DOI · Paper page
  22. Hall, 2017, p16(Ink4a) and senescence-associated beta-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli, Aging (Albany N. Y.), 9, 1867
  23. Hassona, 2014, Senescent cancer-associated fibroblasts secrete active MMP-2 that promotes keratinocyte dis-cohesion and invasion, Br. J. Cancer, 111, 1230, 10.1038/bjc.2014.438 · DOI · Paper page
  24. Hernandez-Segura, 2018, Hallmarks of cellular senescence, Trends Cell Biol., 28, 436, 10.1016/j.tcb.2018.02.001 · DOI · Paper page
  25. Holley, 2012, Manganese superoxide dismutase: beyond life and death, Amino Acids, 42, 139, 10.1007/s00726-010-0600-9 · DOI · Paper page
  26. Huang, 2014, Senescence-associated beta-galactosidase activity marks the visceral endoderm of mouse embryos but is not indicative of senescence, Genesis, 52, 300, 10.1002/dvg.22761 · DOI · Paper page
  27. Huang, 2017, A lysosome-targetable and two-photon fluorescent probe for imaging endogenous β-galactosidase in living ovarian cancer cells, Sens. Actuators B Chem., 246, 833, 10.1016/j.snb.2017.02.158 · DOI
  28. Hubackova, 2019, Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2, Cell Death Differ., 26, 276, 10.1038/s41418-018-0118-3 · DOI
  29. Hubackova, 2019, Mitochondria-driven elimination of cancer and senescent cells, Biol. Chem., 400, 141, 10.1515/hsz-2018-0256 · DOI
  30. Imrali, 2016, Rapamycin inhibits prostate cancer cell growth through cyclin D1 and enhances the cytotoxic efficacy of cisplatin, Am. J. Cancer Res., 6, 1772
  31. Jiang, 2017, A selective and light-up fluorescent probe for β-galactosidase activity detection and imaging in living cells based on an AIE tetraphenylethylene derivative, Chem. Commun., 53, 4505, 10.1039/C7CC00249A · DOI
  32. Kaefer, 2014, Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia, Cancer Chemother. Pharmacol., 74, 593, 10.1007/s00280-014-2530-9 · DOI · Paper page
  33. Kamiya, 2007, An enzymatically activated fluorescence probe for targeted tumor imaging, J. Am. Chem. Soc., 129, 3918, 10.1021/ja067710a · doi:10.1021/ja067710a
  34. Kamiya, 2011, Beta-galactosidase fluorescence probe with improved cellular accumulation based on a spirocyclized rhodol scaffold, J. Am. Chem. Soc., 133, 12960, 10.1021/ja204781t · DOI · Paper page
  35. Kaur, 2018, Aptamers in the therapeutics and diagnostics pipelines, Theranostics, 8, 4016, 10.7150/thno.25958 · DOI · Paper page
  36. Keefe, 2010, Aptamers as therapeutics, Nat. Rev. Drug Discov., 9, 537, 10.1038/nrd3141 · DOI · Paper page
  37. Kim, 2008, Identification of replicative senescence-associated genes in human umbilical vein endothelial cells by an annealing control primer system, Exp. Geronotol., 43, 286, 10.1016/j.exger.2007.12.010 · DOI
  38. Kirschner, 2020, Functional heterogeneity in senescence, Biochem. Soc. Trans., 48, 765, 10.1042/BST20190109 · DOI
  39. Kohli, 2021, Algorithmic assessment of cellular senescence in experimental and clinical specimens, Nat. Protoc., 16, 2471, 10.1038/s41596-021-00505-5 · DOI · Paper page
  40. Kopp, 2007, Beta-galactosidase staining on bone marrow. The osteoclast pitfall, Histol. Histopathol., 22, 971
  41. Krishna, 1999, Does pH 6 beta-galactosidase activity indicate cell senescence?, Mech. Ageing Dev., 109, 113, 10.1016/S0047-6374(99)00031-7 · DOI
  42. Krtolica, 2001, Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging, Proc. Natl. Acad. Sci. U. S. A., 98, 12072, 10.1073/pnas.211053698 · DOI · Paper page
  43. Krueger, 2018, Abstract LB-369: in vivo imaging of tumor senescence with a novel beta-galactosidase specific PET tracer, Cancer Res., 78, 10.1158/1538-7445.AM2018-LB-369 · DOI
  44. Lai, 2016, A Novel PD-L1-targeting antagonistic DNA aptamer with antitumor effects, Mol. Ther. Nucleic Acids, 5, 10.1038/mtna.2016.102 · DOI · Paper page
  45. Lee, 2019, The dynamic nature of senescence in cancer, Nat. Cell Biol., 21, 94, 10.1038/s41556-018-0249-2 · DOI · Paper page
  46. Lee, 2014, Ratiometric two-photon fluorescent probe for quantitative detection of beta-galactosidase activity in senescent cells, Anal. Chem., 86, 10001, 10.1021/ac5031013 · DOI
  47. Lewinska, 2020, AMPK-mediated senolytic and senostatic activity of quercetin surface functionalized Fe3O4 nanoparticles during oxidant-induced senescence in human fibroblasts, Redox Biol., 28, 10.1016/j.redox.2019.101337 · DOI
  48. Li, 2020, Chiral Cux Coy S nanoparticles under magnetic field and NIR light to eliminate senescent cells, Angew. Chem. Int. Ed. Engl., 59, 13915, 10.1002/anie.202004575 · DOI
  49. Lozano-Torres, 2017, An OFF-ON two-photon fluorescent probe for tracking cell senescence in vivo, J. Am. Chem. Soc., 139, 8808, 10.1021/jacs.7b04985 · DOI · Paper page
  50. Lozano-Torres, 2019, The chemistry of senescence, Nat. Rev. Chem., 3, 426, 10.1038/s41570-019-0108-0 · DOI · Paper page
  51. Lozano-Torres, 2020, Real-time in vivo detection of cellular senescence through the controlled release of the NIR fluorescent dye nile blue, Angew. Chem. Int. Ed. Engl., 59, 15152, 10.1002/anie.202004142 · DOI
  52. Lozano-Torres, 2021, A two-photon probe based on naphthalimide-styrene fluorophore for the in vivo tracking of cellular senescence, Anal. Chem., 93, 3052, 10.1021/acs.analchem.0c05447 · DOI
  53. Lu, 2020, Mitochondria-targeting Plasmonic spiky nanorods increase the elimination of aging cells in vivo, Angew. Chem. Int. Ed. Engl., 59, 8698, 10.1002/anie.202002576 · DOI
  54. Marmary, 2016, Radiation-induced loss of salivary gland function is driven by cellular senescence and prevented by IL6 modulation, Cancer Res., 76, 1170, 10.1158/0008-5472.CAN-15-1671 · DOI
  55. Mitchell, 2021, Engineering precision nanoparticles for drug delivery, Nat. Rev. Drug Discov., 20, 101, 10.1038/s41573-020-0090-8 · DOI · Paper page
  56. Morsli, 2021, The use of geroprotectors to prevent multimorbidity: opportunities and challenges, Mech. Ageing Dev., 193, 10.1016/j.mad.2020.111391 · DOI
  57. Mukherjee, 2020, Recent advancements of magnetic nanomaterials in cancer therapy, Pharmaceutics, 12
  58. Munk, 2021, Acid ceramidase promotes senescent cell survival, Aging (Albany N. Y.), 13, 15750
  59. Mylonas, 2021, Cellular senescence inhibits renal regeneration after injury in mice, with senolytic treatment promoting repair, Sci. Transl. Med., 13, 10.1126/scitranslmed.abb0203 · DOI · Paper page
  60. Ni, 2017, Chemical modifications of nucleic acid aptamers for therapeutic purposes, Int. J. Mol. Sci., 18
  61. Nishida, 2000, Localization of CD9, an enhancer protein for proheparin-binding epidermal growth factor-like growth factor, in human atherosclerotic plaques: possible involvement of juxtacrine growth mechanism on smooth muscle cell proliferation, Arterioscler. Thromb. Vasc. Biol., 20, 1236, 10.1161/01.ATV.20.5.1236 · DOI
  62. Ou, 2020, Cellular senescence in cancer: from mechanisms to detection, Mol. Oncol., 15, 2634, 10.1002/1878-0261.12807 · DOI · Paper page
  63. Oushiki, 2012, Near-infrared fluorescence probes for enzymes based on binding affinity modulation of squarylium dye scaffold, Anal. Chem., 84, 4404, 10.1021/ac300061a · DOI
  64. Paez-Ribes, 2019, Targeting senescent cells in translational medicine, EMBO Mol. Med., 11, 10.15252/emmm.201810234 · DOI · Paper page
  65. Parisotto, 2017, Senescence controls prostatic neoplasia driven by Pten loss. 2018, Mol. Cell. Oncol., 6
  66. Park, 2021, Endothelial cell senescence: a machine learning-based meta-analysis of transcriptomic studies, Ageing Res. Rev., 65
  67. Peng, 2019, Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness, Nat. Nanotechnol., 14, 279, 10.1038/s41565-018-0356-z · DOI · Paper page
  68. Pham, 2021, Targeting and clearance of senescent foamy macrophages and senescent endothelial cells by antibody-functionalized mesoporous silica nanoparticles for alleviating aorta atherosclerosis, Biomaterials, 269, 10.1016/j.biomaterials.2021.120677 · DOI · Paper page
  69. Plovins, 1994, Use of fluorescein-di-beta-D-galactopyranoside (FDG) and C12-FDG as substrates for beta-galactosidase detection by flow cytometry in animal, bacterial, and yeast cells, Appl. Environ. Microbiol., 60, 4638, 10.1128/aem.60.12.4638-4641.1994 · DOI
  70. Te Poele, 2002, DNA damage is able to induce senescence in tumor cells in vitro and in vivo, Cancer Res., 62, 1876
  71. Prodeus, 2018, A synthetic cross-species cd200r1 agonist suppresses inflammatory immune responses in vivo, Mol. Ther. Nucleic Acids, 12, 350, 10.1016/j.omtn.2018.05.023 · DOI
  72. Qu, 2020, An nir-responsive dna-mediated nanotetrahedron enhances the clearance of senescent cells, Adv. Mater., 32, 10.1002/adma.202000184 · DOI · Paper page
  73. Rose, 2010, Capillary electrophoretic development of aptamers for a glycosylated VEGF peptide fragment, Analyst, 135, 2945, 10.1039/c0an00445f · DOI
  74. Schwenck, 2019, In vivo imaging of tumor senescence with a novel beta-galactosidase specific PET tracer, Nuklearmedizin, 58, L5
  75. Serrano, 1993, A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4, Nature, 366, 704, 10.1038/366704a0 · DOI · Paper page
  76. Sidi, 2011, Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis, Eur. J. Cancer (Oxford, England: 1990), 47
  77. Soto-Gamez, 2017, Therapeutic interventions for aging: the case of cellular senescence, Drug Discov. Today, 22, 786, 10.1016/j.drudis.2017.01.004 · DOI · Paper page
  78. Storer, 2013, Senescence is a developmental mechanism that contributes to embryonic growth and patterning, Cell, 155, 1119, 10.1016/j.cell.2013.10.041 · DOI · Paper page
  79. Takasugi, 2018, Emerging roles of extracellular vesicles in cellular senescence and aging, Aging Cell, 17, 10.1111/acel.12734 · DOI · Paper page
  80. Tang, 2017, A universal fluorometric assay strategy for glycosidases based on functional carbon quantum dots: β-galactosidase activity detection in vitro and in living cells, J. Mater. Chem. B, 5, 1971, 10.1039/C6TB03361J · DOI
  81. Tato-Costa, 2016, Therapy-induced cellular senescence induces epithelial-to-mesenchymal transition and increases invasiveness in rectal cancer, Clin. Colorectal Cancer, 15
  82. Tung, 2004, In vivo imaging of beta-galactosidase activity using far red fluorescent switch, Cancer Res., 64, 1579, 10.1158/0008-5472.CAN-03-3226 · DOI · Paper page
  83. Tuttle, 2021, Senescence in tissue samples of humans with age-related diseases: a systematic review, Ageing Res. Rev., 68, 10.1016/j.arr.2021.101334 · DOI · Paper page
  84. Untergasser, 2003, TGF-beta cytokines increase senescence-associated beta-galactosidase activity in human prostate basal cells by supporting differentiation processes, but not cellular senescence, Exp. Gerontol., 38
  85. Wang, 2009, DNA damage response and cellular senescence in tissues of aging mice, Aging Cell, 8, 311, 10.1111/j.1474-9726.2009.00481.x · DOI · Paper page
  86. Wang, 2010, Two-photon microscopy of deep intravital tissues and its merits in clinical research, J. Microsc., 238, 1, 10.1111/j.1365-2818.2009.03330.x · DOI · Paper page
  87. Wang, 2017, Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism, Aging Cell, 16, 564, 10.1111/acel.12587 · DOI · Paper page
  88. Wang, 2017, Development of a long-lived luminescence probe for visualizing beta-galactosidase in ovarian carcinoma cells, Anal. Chem., 89, 11679, 10.1021/acs.analchem.7b03114 · DOI
  89. Wani, 2019, Nanoparticle opsonization: forces involved and protection by long chain polymers, Polym. Bull., 77, 3865, 10.1007/s00289-019-02924-7 · DOI
  90. Wehrman, 2006, Luminescent imaging of beta-galactosidase activity in living subjects using sequential reporter-enzyme luminescence, Nat. Methods, 3, 295, 10.1038/nmeth868 · DOI
  91. Wu, 2007, Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation, Proc. Natl. Acad. Sci. U. S. A., 104, 13028, 10.1073/pnas.0701953104 · DOI · Paper page
  92. Xu, 2019, Beta-Galactosidase instructed supramolecular hydrogelation for selective identification and removal of senescent cells, Chem. Commun. (Camb.), 55, 7175, 10.1039/C9CC03056E · DOI
  93. Xue, 2007, Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas, Nature, 445, 656, 10.1038/nature05529 · DOI · Paper page
  94. Yi, 2020, NMR-based metabonomic analysis of HUVEC cells during replicative senescence, Aging (Albany N. Y.), 12, 3626
  95. Yudoh, 2010, Statin prevents chondrocyte aging and degeneration of articular cartilage in osteoarthritis (OA), Aging (Albany N. Y.), 2, 990
  96. Yun, 2015, Recurrent turnover of senescent cells during regeneration of a complex structure, Elife, 4, e05505, 10.7554/eLife.05505 · DOI · Paper page
  97. Zhang, 2017, A novel near-infrared fluorescent probe for sensitive detection of beta-galactosidase in living cells, Anal. Chim. Acta, 968, 97, 10.1016/j.aca.2017.02.039 · DOI · Paper page
  98. Zheng, 2017, Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth, Theranostics, 7, 1373, 10.7150/thno.17826 · DOI
  99. Zhou, 2021, Hallmarks and detection techniques of cellular senescence and cellular ageing in immune cells, Aging Cell, 20, 10.1111/acel.13316 · DOI · Paper page
  100. Zhu, 2013, Sunitinib induces cellular senescence via p53/Dec1 activation in renal cell carcinoma cells, Cancer Sci., 104, 1052, 10.1111/cas.12176 · DOI · Paper page

Cited by

See all 42

Metadata

Authors
Morsli, S., Doherty, G. J., & Muñoz-Espín, D.
Venue
Mechanisms of Ageing and Development
Publisher
Elsevier BV
Published
2022-03
Volume
202
Pages
111618
ISSN
0047-6374 (ISSN-L)
OpenAlex
W4205636715
Cited by
42
References
137
FWCI
4.88
Type
journal article
Language
en
Open access
green
Funders
  • Cancer Research UK (C62187/A26989, C62187/A29760, RG86786)
  • Medical Research Council (MR/R000530/1)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cells. https://app.cochat.ai/papers/10.1016/j.mad.2021.111618
The paper
Morsli, S., Doherty, G. J., & Muñoz-Espín, D. (2022). Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cells. Mechanisms of Ageing and Development. https://doi.org/10.1016/j.mad.2021.111618

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.